Trial record 1 of 55 for:    obstetrics | NICHD
Previous Study | Return to List | Next Study

Emergency Obstetric and Neonatal Care: The EmONC Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
ClinicalTrials.gov Identifier:
NCT01073488
First received: February 21, 2010
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

The objective of this cluster randomized controlled trial is to reduce maternal and neonatal mortality by increasing access to and improving the quality of obstetric and neonatal care for pregnant women in study clusters. It is hypothesized that a 25% reduction in >28 week or >1000 gram stillbirth and 7-day neonatal mortality will be achieved in the intervention clusters by a multifaceted Emergency Obstetric Neonatal Care (EmONC) package that will be introduced by an EmONC team.


Condition Intervention
Conditions Involved in Maternal Morbidity and Mortality
Conditions Contributing to Stillbirth and Neonatal Deaths
Behavioral: Community Mobilization
Behavioral: Home-based Life Saving Skills
Behavioral: Facility improvement

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Evaluation of an Emergency Obstetric and Neonatal Care (EmONC) Intervention Package to Reduce Adverse Pregnancy Outcomes in Low Resource Settings (The EmONC Trial)

Resource links provided by NLM:


Further study details as provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):

Primary Outcome Measures:
  • Composite of either >28 week / >1000 gram stillbirth or 7 day neonatal mortality rate [ Time Frame: 7 days post delivery ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Maternal mortality rate [ Time Frame: 42 days post delivery ] [ Designated as safety issue: No ]
  • Maternal morbidity rates [ Time Frame: 42 days post delivery ] [ Designated as safety issue: No ]
  • Stillbirth rate [ Time Frame: Delivery ] [ Designated as safety issue: No ]
  • 7-day neonatal mortality rate [ Time Frame: 7 days post delivery ] [ Designated as safety issue: No ]
  • 28-day neonatal mortality rate [ Time Frame: 28 days post delivery ] [ Designated as safety issue: No ]
  • Rates of mothers transported to a referral hospital. [ Time Frame: 42 days post delivery ] [ Designated as safety issue: No ]
  • Rates of neonates/infants transported to a referral hospital [ Time Frame: 42 days post delivery ] [ Designated as safety issue: No ]

Estimated Enrollment: 54000
Study Start Date: December 2008
Estimated Study Completion Date: October 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Community mobilization Behavioral: Community Mobilization
Mobilization of the community, with special emphasis on pregnant women and their families, to identify resources and solutions to improve maternal and neonatal mortality.
Other Name: CM
Home-based life saving skills Behavioral: Home-based Life Saving Skills
Training of community birth attendants (skilled and unskilled) to recognize problems, stabilize and refer pregnant women and their newborns, as appropriate.
Other Name: HBLSS
Facility improvement Behavioral: Facility improvement
Facility improvement through staff training to ensure that once a pregnant woman and her newborn reaches the referral facility, appropriate services are available.

Detailed Description:

Maternal death, stillbirth, early neonatal death, and obstetric fistula are among the most devastating adverse outcomes of pregnancy. Existing interventions could avert the majority of maternal and neonatal deaths; however, those women at greatest risk are least likely to have access to interventions delivered through the formal health care system. In many developing countries, most deliveries in rural areas and a significant number in urban areas are conducted at home without skilled attendance, circumstances which pose a high risk for both mothers and their neonates. The EmONC trial is designed to evaluate a comprehensive intervention encompassing community mobilization to establish and sustain mechanisms of transport and payment and to drive client-oriented emergency obstetrical and neonatal care. The intervention includes teaching recognition of prolonged labor, infection, preeclampsia and hemorrhage, and the use of appropriate stabilization methods by all community birth attendants. In addition, poor access to quality emergency obstetric and neonatal care in a sustainable manner will be addressed. To evaluate the effectiveness of this approach, a cluster-randomized trial is required to assess whether Cluster EmONC teams can work with the community and health care system to reduce adverse pregnancy outcomes in diverse settings where the majority of deliveries occur at home or at a health clinic with few or no available EmONC interventions. To accomplish the intervention, a train-the-trainer approach will be used. Master trainers will facilitate central and regional training sessions for Country trainers organized around the areas of community mobilization; birth attendant skills; and EmONC referral facility improvements. The Country trainers will then support training and related activities in the intervention clusters, predominantly focusing on these three areas. The study population includes pregnant women (and their neonates) living and delivering in the 108 study clusters. The study clusters are largely rural, geographically distinct communities, each of which have approximately 300 annual deliveries. The women will be enrolled at or after 20 weeks gestation and followed to 42 days post delivery. The total duration of the trial will be 24 months.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Pregnant women living in and/or delivering within the study cluster
  2. Consent provided

Exclusion Criteria: Eligible pregnant women who do not consent

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01073488

Contacts
Contact: Linda Wright, MD 301-402-0830 wrightl@exchange.nih.gov
Contact: Elizabeth McClure, MSc 919-316-3773 mcclure@rti.org

Locations
Argentina
University of Buenos Aires Recruiting
Buenos Aires, Argentina
Contact: José Belizán, MD     011 (54-11) 49534058     belizanj@allstat.org    
Contact: Pierre Buekens, MD, PhD     (504) 988-5397     pbuekens@tulane.edu    
Guatemala
IMSALUD / San Carlos University Recruiting
Guatemala City, Guatemala
Contact: Ana Garcés, MD, MPH     011 (502) 2332-4064     anagarces@imsalud.org    
Contact: Michael Hambidge, MD     (303) 724-3261     michael.hambidge@uchsc.edu    
India
Jawaharlal Nehru Medical College Recruiting
Belgaum, India
Contact: Bhala Khodkany, MD     +91 831 2409 2051     drkodkany@jnmc.edu    
Contact: Richard Derman, MD, MPH     (302) 733-3350     rderman@christianacare.org    
Indira Gandhi Government Medical College Recruiting
Nagpur, India
Contact: Archana Patel, MD     91-98 2315 4463     dr_apatel@yahoo.com    
Contact: Patricia Hibberd, MD, PhD     617-636-2431     patricia.hibberd@tufts.edu    
Kenya
Moi University School of Medicine Recruiting
Eldoret, Kenya
Contact: Fabian Esamai, MD, PhD     254 733 836 410     fesamai@africaonline.co.ke    
Contact: Ed Liechty, MD     317-274-4715     eliecht@iupui.edu    
Pakistan
The Aga Khan University Recruiting
Karachi, Pakistan
Contact: Omrana Pasha, MD     011 (92-21) 486 4948     omrana.pasha@aku.edu    
Contact: Robert Goldenberg, MD     (215) 762-2014     rgoldenb@drexelmed.edu    
Zambia
University Teaching Hospital Recruiting
Lusaka, Zambia
Contact: Elwyn Chomba     011 (260-211) 25-46-55     echomba@zamnet.zm    
Contact: Waldemar Carlo, MD     (205) 934-4680     Wcarlo@PEDS.UAB.EDU    
Sponsors and Collaborators
Investigators
Principal Investigator: Robert Goldenberg, MD Drexel University College of Medicine
  More Information

Additional Information:
No publications provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Linda Wright, M.D, Deputy Director, Center for Research for Mothers and Children, NICHD
ClinicalTrials.gov Identifier: NCT01073488     History of Changes
Other Study ID Numbers: GN EmONC
Study First Received: February 21, 2010
Last Updated: February 21, 2010
Health Authority: United States: Federal Government

Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
Pregnancy
Maternal child health
Developing countries
Stillbirth
Neonatal mortality
Maternal mortality
Community intervention
Community mobilization
Home-based Life Saving Skills

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on May 16, 2013